In the midst of marijuana laws changing quickly across the United States, Pennsylvania has become the first state to permit medical marijuana research at some of its medical schools.
On Thursday, the Department of Health released the guidelines opening applications for medical research. Penn Medicine, Drexel University, and the University of the Sciences have all expressed interest in furthering medical marijuana research, according to NBC10.
“We believe that the research will be of great importance in determining the safety and efficacy of medical cannabis products in treating specific diseases,” the University of Pittsburgh wrote in a statement to NBC10.
Although Ohio and Florida have also looked into similar facets in their medical marijuana programs, neither state has yet to implement such a program, reported NBC10.
Up to eight medical schools could be granted approval for this research program. The state will begin to accept applications next month.
The Department of Health also announced the addition of 13 new medical marijuana growers and 23 new dispensaries in the state. The approved schools will work with authorized growers and dispensers to obtain marijuana for research. [Read more at The Daily Pennsylvanian]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
The process was like the slow burn of a fatty (prescribed for medicinal use only, of course). Last week, five years after Floridians voted to legalize medical marijuana in 2016, state officials announced an “emergency rule” that sets aside one medical marijuana license specifically for a Black farmer. That might seem like a welcome measure to help…
The federal farm bill in 2018 made the substance legal because of its low THC content. Three years after federal legislation removed the marijuana extract known as delta-8 THC from the nation’s list of controlled substances, Texas health officials have put it on its own list of illegal drugs, sending a shockwave through the growing…
The FDA’s failure to regulate a multibillion-dollar market is a detriment to consumers and businesses alike. In August of last year, the Food and Drug Administration held a teleconference with Sarah Brown, the proprietor of Maison Terre, a natural products repackager that Brown ran out of her home in Arkansas. An FDA lab analysis had…
In my 40 years of collecting a paycheck, I gotta admit this has been the oddest business trip I have ever embarked on, beginning with the packed Spirit Airline flight from Baltimore-Washington International Airport to the check-in at the Westgate hotel to grabbing my press credentials Tuesday afternoon at the Las Vegas Convention Center. When…